Kiniksa Pharmaceuticals International Plc (KNSA)
48.82
+0.69
(+1.43%)
USD |
NASDAQ |
Apr 02, 16:00
48.78
-0.04
(-0.08%)
After-Hours: 20:00
Kiniksa Pharmaceuticals International Shareholders Equity (Quarterly) : 567.61M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| NovoCure Ltd. | 340.47M |
| LivaNova Plc | 1.200B |
| Aurinia Pharmaceuticals, Inc. | 581.33M |
| Marker Therapeutics, Inc. | 16.80M |
| Alterola Biotech, Inc. | -- |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 763.63M |
| Total Liabilities (Quarterly) | 196.03M |
| Debt to Equity Ratio | 0.0167 |
| Current Ratio | 3.788 |
| Net Debt Paydown Yield | 0.01% |